01320nas a2200469   4500000000100000000000100001000000100002008004100003653001100044653005200055653002500107653001000132653002100142653001100163653000900174653005300183653002600236653001100262653001500273653005000288653005800338653002000396653002000416653001200436653001600448653001000464653001400474653001400488100001600502700001300518700001300531700001600544700001300560700001400573700001600587700001600603245016500619250001500784300001200799490000800811020003100819       2024                            d10aHumans10a*Chickenpox/economics/drug therapy/epidemiology10aEngland/epidemiology10aChild10aChild, Preschool10aFemale10aMale10a*Anti-Bacterial Agents/therapeutic use/economics10aRetrospective Studies10aInfant10aAdolescent10aHealth Care Costs/statistics & numerical data10aHospitalization/economics/statistics & numerical data10aCost of Illness10aInfant, Newborn10aEngland10aantibiotics10aCosts10apediatric10avaricella1 aS. Kujawski1 aV. Banks1 aC. Casey1 aS. Drysdale1 aA. Patel1 aO. Massey1 aT. Holbrook1 aM. Pawaskar00aThe Clinical and Economic Burden of Antibiotic Use in Pediatric Patients With Varicella Infection: A Retrospective Cohort Analysis of Real-World Data in England  a2024/07/26  ae65-e740 v230  a0022-1899 (Print)0022-1899